Development of Novel Small Molecules as Potential Anti-Cancer Agents

Project Details

StatusActive
Effective start/end date1/1/1512/31/20

Funding

  • Channel Therapeutics Inc.: $62,479.00
  • Channel Therapeutics Inc.: $158,141.76